Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study

Leukemia volume 17, pages 89–97 (2003)Cite this article

Abstract

Various morphometric characteristics of microvessels, highlighted by means of anti-CD34 immunohistochemical staining, were evaluated in the bone marrow of 52 patients with chronic myeloid leukemia (CML) in chronic phase, in relation to several clinicopathologic parameters. Twenty control bone marrows and 15 cases of CML in blastic phase were also studied. Microvessel density (MVD), total vascular area (TVA) and several size- and shape-related parameters were quantitated in the region of most intense vascularization using image analysis. Overall, the group of chronic phase CML had higher MVD and size-related parameters and more branching microvessels than controls. Blastic phase was characterized by increased numbers of microvessels with a rounder shape and smaller caliber than chronic phase. A positive correlation emerged between marrow fibrosis and MVD as well as between white blood cell counts and rounder vessel sections. No relationship existed between microvascular parameters and Hasford or Sokal prognostic scores. In univariate analysis, overall and progression-free survival were adversely affected by MVD, size-related parameters, increased platelet count, age and spleen size. Multivariate analysis indicated that microvessel area was related to progression-free survival, whereas both MVD and area were significant prognosticators of overall survival, even when Hasford or Sokal scores are introduced into the model. Our data suggest that changes in angiogenic parameters may participate in the conversion of normal marrow to CML and ultimately to blastic transformation. More importantly, MVD and microvessel caliber are significant predictors of patient survival and progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Folkman, J. Clinical applications of research on angiogenesis. N Engl J Med, (1995). 333, 1757–1763.

    Article  CAS  Google Scholar 

  2. Schnitt, SJ The real value of angiogenesis research in breast cancer. Adv Anat Path, (1997). 4, 23–27.

    Article  Google Scholar 

  3. Srivastava, A, Laidler, P, Davies, RP, Horgan, K & Hughes, LE The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol, (1988). 133, 419–423.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Korkolopoulou, P, Konstantinidou, AE, Kavantzas, N, Patsouris, E, Pavlopoulos, PM, Christodoulou, P, Thomas-Tsagli, E & Davaris, P Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virch Arch, (2001). 438, 603–611.

    Article  CAS  Google Scholar 

  5. Brawer, MK, Deering, RE, Brown, M, Preston, SD & Bigler, SA Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer, (1994). 73, 678–687.

    Article  CAS  Google Scholar 

  6. Pavlopoulos, PM, Konstantinidou, AE, Agapitos, E, Kavantzas, N, Nikolopoulou, P & Davaris, P A morphometric study of neovascularization in colorectal carcinoma. Cancer, (1998). 83, 2067–2075.

    Article  CAS  Google Scholar 

  7. Yamazaki, K, Abe, S, Tagekawa, H, Sukoh, N, Watanabe, N, Ogura, S, Nakajima, I, Isobe, H, Inoue, K & Kawakami, Y Tumor angiogenesis in human lung adenocarcinoma. Cancer, (1994). 74, 2245–2250.

    Article  CAS  Google Scholar 

  8. Bruyn, PPH, Breen, PC & Thomas, TB The microcirculation of the bone marrow. Anat Rec, (1970). 168, 55–68.

    Article  Google Scholar 

  9. Mangi, MH Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol, (2000). 111, 43–51.

    Article  CAS  Google Scholar 

  10. Choi, K, Kennedy, M, Kazarov, A, Papadimitriou, JC & Keller, G A common precursor for hematopoietic and endothelial cells. Development, (1998). 125, 725–732.

    CAS  Google Scholar 

  11. Yamaguchi, H, Ishii, E, Saito, S, Tashiro, K, Fujita, I, Yoshidani, S, Ohtubo, M, Akazawa, K & Miyazaki, S Umbilical vein endothelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells. Br J Haematol, (1996). 94, 606–611.

    Article  CAS  Google Scholar 

  12. Fiedler, W, Graeven, U, Ergn, S, Verago, S, Kilie, N, Stockschlader, M & Hossfeld, DK Vascular endothelial growth factor, a possible paracrine growth factor, in human acute myeloid leukemia. Blood, (1997). 89, 1870–1875.

    CAS  PubMed  Google Scholar 

  13. Vacca, A, Ribatti, D, Roncali, L, Ranieri, G, Serio, G, Silvestris, F & Dammacco, F Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol, (1994). 87, 503–508.

    Article  CAS  Google Scholar 

  14. Ribatti, D, Vacca, A, Nico, B, Fanelli, M, Roncali, L & Dammacco, F Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and structural study. Eur J Haematol, (1996). 56, 45–53.

    Article  CAS  Google Scholar 

  15. Perez-Atayde, AR, Sallan, SE, Tedrow, V, Connors, S, Allred, E & Folkman, J Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol, (1997). 150, 815–821.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Aguayo, A, Kantarjian, H, Manshouri, T, Gidel, C, Estey, E, Thomas, D, Koller, C, Estror, Z, O’Brien, S, Keating, M, Freireich, E & Albitar, M Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, (2000). 96, 2240–2245.

    CAS  PubMed  Google Scholar 

  17. Padrö, T, Ruiz, S, Bieker, R, Burger, H, Steins, M, Kienast, J, Buchner, T, Berdel, WE & Mesters, RM Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood, (2000). 95, 2637–2644.

    PubMed  Google Scholar 

  18. de Bont, ESJM, Rosati, S, Jacobs, S, Kamps, WA & Vellenga, E Increased bone marrow vascularization in patients with acute myeloid leukemia: a possible role for vascular endothelial growth factor. Br J Haematol, (2001). 113, 296–304.

    Article  CAS  Google Scholar 

  19. Aguayo, A, Estey, E, Kantarjian, H, Manshouri, T, Gidel, C, Keating, M, Giles, F, Estror, Z, Barlogie, B & Albitar, M Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood, (1999). 94, 3717–3721.

    CAS  PubMed  Google Scholar 

  20. Aguayo, A, O’Brien, S, Keating, M, Manshouri, T, Gidel, C, Barlogie, B, Beran, M, Keller, C, Kantarjian, H & Albitar, M Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia. Blood, (2000). 96, 768–770.

    CAS  PubMed  Google Scholar 

  21. Salven, P, Orpana, A, Teerenhovi, L & Joensuu, H Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and βFGF is an independent predictor of poor prognosis in non-Hodgkin's lymphoma: a single-institution study of 200 patients. Blood, (2000). 96, 3712–3718.

    CAS  Google Scholar 

  22. Lundberg, LG, Lerner, R, Sundelin, P, Rogers, R, Folkman, J & Palmblad, J Bone marrow in polycythemia vera, chronic myelocytic leukemia and myelofibrosis has an increased vascularity. Am J Pathol, (2000). 157, 15–19.

    Article  CAS  Google Scholar 

  23. Verstovsek, S, Kantarjian, H, Manshouri, T, O’Brien, S, Faderl, S, Talpaz, M, Cortes, J & Albitar, M Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia. Cancer, (2002). 94, 1517–1521.

    Article  CAS  Google Scholar 

  24. Gunsilius, E, Duba, HC, Petzer, AL, Kahler, CM, Grunewald, K, Stockhammer, G, Gabl, C, Dirnhofer, S, Clausen, J & Gastl, G Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet, (2000). 355, 1688–1691.

    Article  CAS  Google Scholar 

  25. Harris, NL, Jaffe, ES, Diebold, J, Flandrin, G, Muller-Hermenlink, HK, Vardiman, J, Lister, TA & Bloomfield, CD The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology, (2000). 36, 69–87.

    Article  CAS  Google Scholar 

  26. Hasford, J, Pfirrmann, M, Hehlmann, R, Allan, NC, Baccarani, M, Johanna, C, Nelemans, K, Alimena, G, Steegmann, JL & Ansari, H A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. J Natl Cancer Inst, (1998). 90, 850–858.

    Article  CAS  Google Scholar 

  27. Sokal, J, Cox, E, Baccarani, M, Tura, S, Gomez, GA, Robertson, JE, Tso, CY, Braun, TJ, Clarkson, BD, Cervantes, F & Rozman, C the Italian Cooperative CML Study Group Prognostic discrimination in ‘good risk’ chronic granulocytic leukemia. Blood, (1984). 63, 1352–1357.

    Google Scholar 

  28. Mesa, RA, Hanson, CA, Rajkumar, V, Schroeder, G & Tefferi, A Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood, (2000). 96, 3374–3380.

    CAS  PubMed  Google Scholar 

  29. Pruneri, G, Bertolini, F, Soligo, D, Carboni, N, Cortelezzi, A, Ferucci, PF, Buffa, R, Lambertenghi-Deliliers, G & Pezzela, F Angiogenesis in myelodysplastic syndromes. Br J Cancer, (1999). 81, 1398–1401.

    Article  CAS  Google Scholar 

  30. Shi, SR, Key, ME & Kalra, K Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem, (1991). 39, 741–748.

    Article  CAS  Google Scholar 

  31. Hsu, SM, Raine, L & Fanger, H Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem, (1981). 29, 577–580.

    Article  CAS  Google Scholar 

  32. Vermeulen, PB, Gasparini, G, Fox, SB, Toi, M, Martin, L, McCulloch, P, Pezzela, F, Viale, G, Weidner, N, Harris, AL & Dirix, LY Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer, (1996). 32, 2474–2484.

    Article  Google Scholar 

  33. Weidner, N, Folkman, J, Pozza, F & Bevilacqua, P Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, (1992). 84, 1875–1887.

    Article  CAS  Google Scholar 

  34. Fox, E & Ulrich, C Sigma Scan Image Measurement Software, User's Electronic Manual. (1995). Sigma Scan, Jandel Scientific: Erkrath, Germany

  35. Branemark, P-I Bone marrow microvascular structure and function. Adv Microcirc, (1968). 1, 1–65.

    Google Scholar 

  36. Korkolopoulou, P, Apostolidou, E, Pavlopoulos, PM, Kavantzas, N, Vyniou, N, Thymara, I, Terpos, E, Patsouris, E, Yataganas, X & Davaris, P Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia, (2001). 15, 1369–1376.

    Article  CAS  Google Scholar 

  37. Benjamin, LE & Keshet, E Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA, (1997). 94, 8761–8766.

    Article  CAS  Google Scholar 

  38. Patan, S, Munn, LL & Jain, PK Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc Res, (1996). 51, 260–272.

    Article  CAS  Google Scholar 

  39. Garcia-Monzon, C, Sanchez-Madrid, F, Garcia-Buey, L, Garcia-Arroyo, A, Garcia-Sanchez, A & Moreno-Otero, R Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology, (1995). 108, 231–241.

    Article  CAS  Google Scholar 

  40. Bellamy, WT, Richter, L, Sirjani, D, Roxas, C, Glinsmann-Gibson, B, Frutiger, Y, Grogan, TM & List, AF VEGF is an autocrine promoter of abnormal localized immature myeloid precursors and leukemic progenitor formation in myelodysplastic syndromes. Blood, (2001). 97, 1427–1434.

    Article  CAS  Google Scholar 

  41. Green, AR Hemangioblast origin of chronic myeloid leukaemia?. Lancet, (2000). 355, 1659–1660.

    Article  CAS  Google Scholar 

  42. Rajkumar, SV, Leong, T, Roche, PC, Fonseca, R, Dispenzieri, A, Lacy, M, Lust, JA, Witzig, TE, Kyle, RA, Gertz, MA & Greipp, PR Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res, (2000). 6, 3111–3116.

    CAS  PubMed  Google Scholar 

  43. Zhong, H, De Marzo, AM, Laughner, E, Lim, M, Hilton, DA, Zagzag, D, Buechler, P, Isaacs, WB, Scmenza, GL & Simons, JW Overexression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res, (1999). 59, 5830–5835.

    CAS  Google Scholar 

  44. Rajkumar, SV, Dispenzieri, A, Fonseca, R, Lacy, MR, Geyer, S, Lust, JA, Kyle, RA, Greipp, PR, Gertz, MA & Witzig, TE Thalidomide for previously untreated indolent or smoldering multiple myeloma. Leukemia, (2001). 15, 1274–1276.

    Article  CAS  Google Scholar 

  45. Barosi, G, Grossi, A, Comotti, B, Musto, P, Gamba, G & Marchetti, M Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. Br J Haematol, (2001). 114, 78–83.

    Article  CAS  Google Scholar 

  46. Raza, A, Meyer, P, Dutt, D, Zorat, F, Lisak, L, Nascimben, F, du Randt, M, Kaspar, C, Goldberg, C, Loew, J, Dar, S, Gezer, S, Venugopal, P & Zeldis, J Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Blood, (2001). 98, 958–965.

    Article  CAS  Google Scholar 

  47. Harris, AL Antiangiogenesis for cancer therapy. Lancet, (1997). 349, 13–15.

    Article  CAS  Google Scholar 

  48. Druker, BJ & Lydon, NB Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest, (2000). 105, 3–7.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Miss Evie Delicha for the statistical analysis of results.

Author information

Authors and Affiliations

  1. Department of Pathology, National and Capodistrian University of Athens, Greece

    P Korkolopoulou, N Kavantzas, E Patsouris, I Thymara, P M Pavlopoulos & P Davaris

  2. First Department of Internal Medicine, National and Capodistrian University of Athens, Greece

    N Viniou, E Terpos, K Stamatopoulos, E Plata, K Anargyrou, A Androulaki & X Yataganas

Authors
  1. P Korkolopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Viniou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Kavantzas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Patsouris
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Thymara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P M Pavlopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E Terpos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K Stamatopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. E Plata
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K Anargyrou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A Androulaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. P Davaris
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. X Yataganas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korkolopoulou, P., Viniou, N., Kavantzas, N. et al. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study. Leukemia 17, 89–97 (2003). https://doi.org/10.1038/sj.leu.2402769

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402769

Keywords

This article is cited by

Search

Advanced search

Quick links